Lupus Science & Medicine

Papers
(The H4-Index of Lupus Science & Medicine is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Evaluation and randomised controlled trial of home urinalysis testing in patients with SLE at elevated risk for developing lupus nephritis: a study protocol49
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort44
Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality43
Combining mepacrine with hydroxychloroquine-based therapy in active systemic lupus erythematosus: an observational study of 106 patients from the Lupus-Cruces cohort37
Towards a minimal core dataset for systemic lupus erythematosus studies35
B lymphocytes in treatment-naive paediatric patients with lupus are epigenetically distinct from healthy children33
Autoantibody-based subgroups and longitudinal seroconversion in juvenile-onset systemic lupus erythematosus32
Differences in reproductive health discussions in an urban Hispanic population with SLE: lessons from the field26
Genetic load in incomplete lupus erythematosus26
Novel multiclass classification machine learning approach for the early-stage classification of systemic autoimmune rheumatic diseases25
Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms25
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease24
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE24
High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus23
Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials22
Langerhans cells infiltration in lymph nodes of patients with systemic lupus erythematosus22
Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response21
Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE wit21
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine21
A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort20
VPS13C and STING expression in neuropsychiatric systemic lupus erythematosus: unveiling an unbreached territory20
0.19187998771667